Icon

COBENFY - (20MG;50MG, 20MG;100MG, 30MG;125MG)

TROSPIUM CHLORIDE; XANOMELINE TARTRATE None
20MG;50MG, 20MG;100MG, 30MG;125MG
Less Than $1000 mn
None None
None None
None None
COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults.
Yes
COBENFY Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.